BCL2 and lung cancer: Furthermore, the overexpression of NF-κB in lung cancer potentiates its development and progression by promoting the expression of the anti-apoptotic Bcl-2 family and suppressing that of pro-apoptotic proteins, thus promoting proliferation and preventing apoptosis [53].